New Research Suggests Lithium Levels May Impact Alzheimer’s Disease
Recent findings from Harvard Medical School reveal that low lithium levels in the brain could play a role in the development of Alzheimer’s disease. Lithium, a substance known for its ability to help manage mood swings and protect brain cells, is already used as a treatment for Bipolar Disorder and depression.
According to the researchers, lithium might be a key factor in Alzheimer’s risk. They conducted experiments on mice and analyzed human brain samples to study the effects of lithium.
The human brain samples were gathered through the Rush Memory and Aging Project in Chicago, which keeps records of brain tissue from many donors. These samples covered various stages of cognitive health, including individuals with no signs of Alzheimer’s, those with mild cognitive impairment, and patients with advanced Alzheimer’s.
The study found that as Alzheimer’s progressed, lithium levels decreased significantly. “This is the first time anyone has demonstrated that lithium is present at a natural level that is biologically significant without using it as a medication,” noted Bruce Yankner, a senior author of the study.
As amyloid plaques, which are characteristic of Alzheimer’s, accumulate in the brain, they attach to lithium, preventing it from functioning effectively as a protector. In experiments where mice were put on a low-lithium diet, their brain levels dropped, leading to faster aging, more plaque formation, increased inflammation, and memory loss.
Yankner explained that lithium is similar to other essential nutrients, like iron and vitamin C. A new lithium compound, called lithium orotate, was discovered during the research. This compound did not bind to amyloid and showed promise in restoring memory and repairing brain damage in mice, even those at advanced stages of Alzheimer’s.
However, experts caution that while these findings are promising, there are limitations. Ozama Ismail, Ph.D., from the Alzheimer’s Association, mentioned that animal studies cannot directly replicate human Alzheimer’s. He emphasized the need for further research, particularly large clinical trials, to truly understand how lithium affects human health.
If confirmed, these findings could lead to simple blood tests for lithium levels, helping identify individuals at risk for Alzheimer’s in the future. Researchers are optimistic, but they also warn against self-medicating with lithium-based treatments until more is known.
With additional studies, the hope is that lithium can provide a more powerful method for combating cognitive decline, potentially improving the lives of those affected by Alzheimer’s disease.
